ClinicalTrials.gg
CompletedNCT03390348LENUSUpdated Aug 17, 2018

An In-home Observational Study to Compare Infant Crying and Fussing Parameters Documented by the LENA Recorder With Those Documented Via Parental E-diaries

An observational study in Crying and Fussy Infant (Baby), sponsored by Danone Asia Pacific Holdings Pte, Ltd.. Completed at 1 site in United States. Open to participants aged Up to 15 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-17.

Sponsored by Danone Asia Pacific Holdings Pte, Ltd. (part of Danone) · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
12
Ages
Up to 15 Weeks
Sex
All
01

Study summary

This is a in-home observational study of 12 healthy term infants of ≤15 weeks of age to compare infant crying and fussing parameters documented by the LENA recorder with those documented via parental e-diaries

02

Conditions studied

  • Crying
  • Fussy Infant (Baby)

Browse trials for

03

In context

Crying

39 studies on the registry are indexed under Crying; 8 are open to participants now.

Browse Crying studies →

Lead sponsor

Danone Asia Pacific Holdings Pte, Ltd. is the lead sponsor of 29 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 15 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy term infants of ≤15 weeks of age

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy term infants, age ≤15 weeks
  • Singleton infants (≥37 and ≤42 weeks gestation)
  • Birth weight within normal range for gender and gestational age
  • from parent or legal guardian whose age is ≥18 years old
  • Live in a household with reliable electronic communication capability (e.g. smart phone, computer, internet access)
  • Infants who are breastfed and/or are consuming any commercial infant formula as a major nutrient source
  • Parent's/guardian's English literacy sufficient to follow instructions and complete forms

Exclusion criteria

Exclusion Criteria:

Infants:

  • Currently or within last 30 days prior to screening, participation in any other studies
  • Known to have current or previous illness/condition which could interfere with the study outcome, as per Investigator's clinical judgment

Parents/Guardians of infants:

  • Known to have a significant medical condition (including during pregnancy) that might interfere with the study, as per Investigator's clinical judgment
  • Inability to comply with study protocol, as per the Investigator's judgement
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
12 participants (actual)
Patient registry
No

Interventions

  • DeviceLENA Recorder

    Use of the LENA recorder to document crying and fussing

06

What researchers measure

Primary outcomes

  1. Comparison of the crying and fussing documented by the LENA recorder with the crying and fussing documented in the parental e-diaries

    Comparison of the crying and fussing documented by the LENA recorder with the crying and fussing documented in the parental e-diaries

    Time frame: 14 days

Secondary outcomes

  1. Quantification of inconsolable and unexplainable crying and fussing times based on parental e-diaries

    Quantification of inconsolable and unexplainable crying and fussing times based on parental e-diaries

    Time frame: 14 days

  2. Quantification of inconsolable and unexplainable crying and fussing times detected by the LENA recorder

    Quantification of inconsolable and unexplainable crying and fussing times detected by the LENA recorder

    Time frame: 14 days

Other outcomes

  1. Using a parental questionnaire, investigate the usability of the e-diary and ClaimIt app interface

    Using a parental questionnaire, investigate the usability of the e-diary and ClaimIt app interface

    Time frame: 14 days

  2. Using a parental questionnaire, investigate the usability of the LENA recording device

    Using a parental questionnaire, investigate the usability of the LENA recording device

    Time frame: 14 days

  3. Explore possible correlations between crying and fussing behaviors and infant diet reports

    Explore possible correlations between crying and fussing behaviors and infant diet reports

    Time frame: 14 days

07

Study locations

1 site
  • ObvioHealth
    Orlando, Florida 32826, United States
08

References and documents

Publications

  • Dykstra JR, Sabatos-Devito MG, Irvin DW, Boyd BA, Hume KA, Odom SL. Using the Language Environment Analysis (LENA) system in preschool classrooms with children with autism spectrum disorders. Autism. 2013 Sep;17(5):582-94. doi: 10.1177/1362361312446206. Epub 2012 Jul 2. PubMed 22751753 ↗
  • Canault M, Le Normand MT, Foudil S, Loundon N, Thai-Van H. Reliability of the Language ENvironment Analysis system (LENA) in European French. Behav Res Methods. 2016 Sep;48(3):1109-24. doi: 10.3758/s13428-015-0634-8. PubMed 26174716 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2017 to primary completion in May 2018, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 27, 2017
First posted
Jan 4, 2018
StartActual
Nov 22, 2017
Primary completionActual
May 22, 2018
CompletionActual
May 22, 2018
Last update
Aug 17, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03390348
Collaborators
LENA Foundation, ObvioHealth
Responsible party
Sponsor
First posted
Jan 4, 2018
Start date
Nov 22, 2017
Primary completion
May 22, 2018
Completion
May 22, 2018
Last update
Aug 17, 2018

Study contacts

Parth Shah, MD
principal investigator · Obvio Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion